Ad
related to: biomarin- RareConnections™
Personalized Patient Product
Support From Dedicated Experts.
- Why ROCTAVIAN?
Review Efficacy Data
And Treatment Process.
- Connect With Us
Updates On ROCTAVIAN
Delivered To Your Inbox.
- Important Safety Info
View Important Safety And
And Prescribing Information.
- RareConnections™
Search results
BioMarin (BMRN) Q1 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports encouraging first-quarter results, wherein both earnings and sales beat...
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports mixed Q4 results as it misses estimates for earnings but beats the same for...
BioMarin's (BMRN) Voxzogo Expanded Label Filing Accepted by EMA
Zacks via Yahoo Finance· 1 year agoThe EMA validates BioMarin's (BMRN) label expansion filing for Voxzogo to treat children under two...
Is BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Recent Stock Performance Influenced By Its...
Simply Wall St. via Yahoo Finance· 4 months agoBioMarin Pharmaceutical (NASDAQ:BMRN) has had a great run on the share market with its stock up by a...
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
Insider Sell: EVP, Chief Legal Officer George Davis Sells 13,764 Shares of Biomarin ...
GuruFocus.com via Yahoo Finance· 6 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and...
BioMarin Pharmaceutical (BMRN) Surpasses Q3 Earnings Estimates
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) delivered earnings and revenue surprises of 21.62% and 1.53%, respectively, for the...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript February 22, 2024...
Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out...
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely...
BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock Has Shown Weakness Lately But Financial Prospects...
Simply Wall St. via Yahoo Finance· 11 months agoIt is hard to get excited after looking at BioMarin Pharmaceutical's (NASDAQ:BMRN) recent...
